4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001628280-16-021971
CIK 0001600132operating
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 10:10 AM ET
Size
5.6 KB
Accession
0001628280-16-021971
Insider Transaction Report
Form 4
Luehring Jens
Director10% Owner
Transactions
- Purchase
Common Stock
2016-12-09$0.56/sh+20,000$11,200→ 39,860 total
Holdings
- 3,549,804(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]These shares are owned directly by Linde North America, Inc. ("Linde"). Jens Luehring is a director and chief financial officer of Linde. Mr. Luehring disclaims beneficial ownership of all shares held by Linde, except to the extent of his pecuniary interest therein.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 10:10 AM ET
- Size
- 5.6 KB